His primary areas of study are Epidemiology, Virology, Immunology, Pandemic and Hepatitis C virus. His study in Epidemiology is interdisciplinary in nature, drawing from both Prospective cohort study, Surgery, Intensive care unit and Intensive care. His Virology research is multidisciplinary, relying on both Antibody and Environmental health.
He has included themes like Internal medicine and Risk factor in his Immunology study. His Pandemic research incorporates elements of Young adult, Immunity, Herd immunity and Transmission. Arnaud Fontanet combines subjects such as Multivariate analysis and Hepatitis C with his study of Hepatitis C virus.
Virology, Hepatitis C virus, Immunology, Internal medicine and Hepatitis C are his primary areas of study. His work deals with themes such as Genetics, Serology, Incidence and Genotype, which intersect with Virology. His Immunology research focuses on subjects like Epidemiology, which are linked to Environmental health, Transmission, Pandemic and Psychological intervention.
His Pandemic research includes elements of Young adult and Severe acute respiratory syndrome coronavirus 2. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Surgery and Hepatitis B virus. In his study, Outbreak and Zika virus is strongly linked to Pediatrics, which falls under the umbrella field of Prospective cohort study.
His primary scientific interests are in Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Antibody, Virology and Pandemic. His studies deal with areas such as Epidemiology and 2019-20 coronavirus outbreak as well as Coronavirus disease 2019. He has researched Epidemiology in several fields, including Environmental health, Outbreak, Mass screening, Intensive care medicine and Prevention control.
His work on Zika virus as part of general Virology research is frequently linked to Antibody titer, bridging the gap between disciplines. His research integrates issues of Herd immunity, Young adult, Immunity, Public health and Seroprevalence in his study of Pandemic. As a part of the same scientific family, Arnaud Fontanet mostly works in the field of Herd immunity, focusing on Psychological intervention and, on occasion, Quarantine.
The scientist’s investigation covers issues in Severe acute respiratory syndrome coronavirus 2, Pandemic, Coronavirus disease 2019, Immunity and Serology. Arnaud Fontanet has included themes like Young adult and Herd immunity in his Pandemic study. His Young adult research also works with subjects such as
His study in Herd immunity is interdisciplinary in nature, drawing from both Psychological intervention, Herd and Intensive care. While the research belongs to areas of Psychological intervention, he spends his time largely on the problem of Quarantine, intersecting his research to questions surrounding Epidemiology. His research on Serology also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study
Simon Cauchemez;Marianne Besnard;Priscillia Bompard;Timothée Dub.
The Lancet (2016)
Estimating the burden of SARS-CoV-2 in France.
Henrik Salje;Henrik Salje;Henrik Salje;Cécile Tran Kiem;Cécile Tran Kiem;Noémie Lefrancq;Noémie Courtejoie.
Science (2020)
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
Benoit Guery;Julien Poissy;Loubna El Mansouf;Caroline Séjourné.
The Lancet (2013)
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
Romulus Breban;Julien Riou;Arnaud Fontanet;Arnaud Fontanet.
The Lancet (2013)
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Olivier Lortholary;Marie Desnos-Ollivier;Marie Desnos-Ollivier;Karine Sitbon;Karine Sitbon;Arnaud Fontanet.
Antimicrobial Agents and Chemotherapy (2011)
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010).
Olivier Lortholary;Olivier Lortholary;Charlotte Renaudat;Karine Sitbon;Yoann Madec.
Intensive Care Medicine (2014)
HCV burden of infection in Egypt: results from a nationwide survey.
J. Guerra;M. Garenne;M. Garenne;M. K. Mohamed;A. Fontanet;A. Fontanet.
Journal of Viral Hepatitis (2012)
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Armanda Casrouge;Jérémie Decalf;Mina Ahloulay;Cyril Lababidi.
Journal of Clinical Investigation (2011)
Acute hepatitis C in HIV-infected individuals : recommendations from the European AIDS Treatment Network (NEAT) consensus conference The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel
Matthieu Albert;Jose Benito;Sanjay Bhagani;Christoph Boesecke.
AIDS (2010)
The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
Amr Kandeel;Mohamad Genedy;Samir El‐Refai;Anna L. Funk.
Liver International (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Genentech
Institut Pasteur
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
Université Paris Cité
Institut Pasteur
Université Paris Cité
Institut Pasteur
Université Paris Cité
Institut Pasteur
University of California, Berkeley
East China University of Science and Technology
University of Maryland, College Park
University of Oxford
University of Montpellier
European Bioinformatics Institute
University of Hertfordshire
École Normale Supérieure
State University of Campinas
University of Chile
Clemson University
China National Petroleum Corporation (China)
University of California, Irvine
KU Leuven
University of Erlangen-Nuremberg
International Agency For Research On Cancer